Editorial [Hot topic:Targeted Alpha Particle Therapy (Guest Editors: Ganesan Vaidyanathan and Roy Larsen)]
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
125-126
Author(s):
GANESAN VAIDYANATHAN and ROY H. LARSEN
Commercial Availability of Alpha-Emitting Radionuclides for Medicine
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
127-134
Author(s):
Darrell R. Fisher
Production of Alpha Emitters for Targeted Alpha Therapy
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
135-143
Author(s):
A. Morgenstern, K. Abbas, F. Bruchertseifer and C. Apostolidis
Astatine Radiopharmaceuticals: Prospects and Problems
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
177-196
Author(s):
Ganesan Vaidyanathan and Michael R. Zalutsky
Treatment of Diffuse-Type Gastric Cancer Cells Using 213Bi-Radioimmunoconjugates In Vitro and In Vivo Following Intraperitoneal Dissemination
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
215-224
Author(s):
Christof Seidl and Reingard Senekowitsch-Schmidtke
Targeted α-Particle Therapy: A Clinical Overview
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
251-253
Author(s):
Massimo Salvatori, Luca Indovina and Luigi Mansi
Pharmacogenetics and Inflammatory Bowel Disease
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
6
Page:
201-224
Author(s):
A. M. Phillips, N. C. Hare and J. Satsangi
Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
359-366
Author(s):
C. Braconi, R. Bracci and R. Cellerino
Novel Epigenetic Targets in Lymphoproliferative Disorders
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
378-391
Author(s):
Julio Delgado
Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
392-403
Author(s):
Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome